MIR3668

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, MIR3668 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated MIR3668 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher MIR3668 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3668 expression acts as an unfavorable survival marker.

KIRC, BRCA, and HNSC are the cancer types where MIR3668 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KIRCDFSTertileIII,IV0.1270.744.00272view →
BRCAOSTertileAll0.1130.578.00172view →
HNSCDFSTertileAll0.1630.696.00772view →
READDFSTertileAll0.0820.820<.00172view →
ESCAOSTertileIV0.0950.512.00836view →
UCECDFSTertileAll0.1000.646.02436view →
TGCTDFSTertileII,III,IV0.0880.917.01018view →
SKCMDFSTertileII,III,IV0.2590.567.01612view →
LGGDFSTertileAll0.2160.728.0229view →
Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

MIR3668–KIRC (DFS)

Kaplan–Meier survival curve for MIR3668 RNA-high vs -low samples in KIRC.

Open the KIRC breakdown →

Exploration